河北医科大学学报 ›› 2023, Vol. 44 ›› Issue (1): 16-19,67.doi: 10.3969/j.issn.1007-3205.2023.01.004

• • 上一篇    下一篇

SLC16A11、SLC16A13基因多态性与乙型肝炎相关性肝癌的关联性分析

  

  1. 1.河北省石家庄市疾病预防控制中心性病艾滋病防治所,河北 石家庄050011 ;2.河北医科大学研究生学院,
    河北 石家庄 050017;3.河北医科大学公共卫生学院流行病与卫生统计学教研室、
    河北省环境与人群健康重点实验室,河北 石家庄 050017
  • 出版日期:2023-01-25 发布日期:2023-01-17
  • 作者简介:王莹莹(1979-),女,湖北襄阳人,河北省石家庄市疾病预防控制中心副主任医师,医学硕士,从事传染病预防与控制研究。
  • 基金资助:
    河北省教育厅资助科研项目(ZD2022143)

Association analysis of SLC16A11, SLC16A13 gene polymorphism and hepatitis B-related liver cancer

  1. 1.Institute of STD and AIDS Prevention and Control, Center for Disease Control and Prevention, Hebei 
    Province, Shijiazhuang 050011, China; 2.Graduate School of Hebei Medical University, Shijiazhuang 
    050017, China; 3.Department of Epidemiology and Health Statistics, School of Public Health, 
    Hebei Medical University, Hebei Key Laboratory of Environment 
    and Human Health, Shijiazhuang 050017, China

  • Online:2023-01-25 Published:2023-01-17

摘要:

方法  选取于河北医科大学附属第一医院、第二医院、第四医院和河北省石家庄市第五医院的住院患者和体检人群1 039例。其中乙型肝炎相关性肝癌患者421例,为病例组;健康者370例和HBV自然清除者248例,分别为对照组。采用χ2检验、二分类Logistic回归等统计分析方法,对SLC16A11、SLC16A13基因多态性与乙型肝炎相关性肝癌的关联性进行分析并计算比值比。 
结果  以HBV自然清除人群为对照,与AA基因型相比,携带SLC16A13 rs4796576位点 AG基因型可以显著增加患癌风险(OR=1.544,95%CI:1.073~2.224);与C等位基因相比,在显性模型中,携带G等位基因同样显著增加患癌的风险(OR=1.530,95%CI:1.079~2.170)。
结论  以HBV自然清除人群为对照,SLC16A13 rs4796576基因多态性与乙型肝炎相关性肝癌的罹患有关。


关键词:

Abstract: Objective  To investigate the association between SLC16A11 and SLC16A13 genes and hepatitis B-related liver cancer.  
Methods  In total, 1 039 inpatients and physical examinees were selected from the First Hospital of Hebei Medical University, the Second Hospital of Hebei Medical University, the Fourth Hospital of Hebei Medical University and the Fifth Hospital of Shijiazhuang City, Hebei Province. Among them, 421 patients with hepatitis B-related liver cancer were selected as case group, and 370 healthy people and 248 with natural clearance of HBV as the control group. The association between SLC16A11, SLC16A13 gene polymorphisms and hepatitis B-related liver cancer was analyzed and the odds ratio was calculated by using statistical analysis methods such as χ2 test and binary logistic regression analysis. 
Results  The population with natural clearance of HBV served as controls. When compared with AA genotype, the AG genotype of the SLC16A13 rs4796576 gene could significantly increase the risk of cancer (OR=1.544, 95%CI:1.073-2.224). Compared with the C allele, the dominant model carrying the G allele of the SLC16A13 rs4796576 gene also significantly increased the risk of cancer (OR=1.530, 95%CI:1.079-2.170). 
Conclusion  Compared with the population with naturally clearance of HBV, the SLC16A13 rs4796576 gene polymorphisms is related to hepatitis B-related liver cancer.


Key words: liver neoplasms, hepatitis B, single nucleotide, gene polymorphism